Free Trial

MIRA Pharmaceuticals (MIRA) News Today

MIRA Pharmaceuticals logo
$1.26 -0.14 (-9.96%)
(As of 11/20/2024 ET)
MIRA Continues Solid Financial Management
Mira Pharmaceuticals announces preclinical data on Ketamir-2
MIRA says Ketamir-2 outperforms FDA-approved neuropathic pain treatments
Why Mira Shares Are Trading Higher Today
MIRA Makes Impressive Progress
MIRA Announces Significant Test Results
MIRA Pharmaceuticals, Inc. (K6S.F)
MIRA Pharmaceuticals regains Nasdaq compliance
MIRA Pharmaceuticals, Inc. (MIRA)
MIRA Posts More Positive Test Results
Get MIRA Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for MIRA and its competitors with MarketBeat's FREE daily newsletter.

[625,000% Gain] – Are You Ready for the Next Altcoin Boom? (Ad)

All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.

Register for the FREE Workshop Now & get $10 in Bitcoin

MIRA Media Mentions By Week

MIRA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

MIRA
News Sentiment

1.65

0.45

Average
Medical
News Sentiment

MIRA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

MIRA Articles
This Week

0

1

MIRA Articles
Average Week

Get MIRA Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for MIRA and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:MIRA) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners